[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fx0bA3gDmmlec9rDxuVk6-8-nxHSiZJzX8ffrHJtVrhc":3},{"lesson":4},{"id":5,"slug":6,"article_id":7,"title":8,"body":9,"prevention":10,"framework_refs":11,"status":22,"created_at":23,"published_at":24,"article":25,"tags":29,"podcasts":42},"e4cca4d9-2fef-4106-bcd7-8de2d186647e","czech-court-rules-random-identifiers-in-health-data-constitute-pseudonymization-not-anonymization","992b7825-99d7-4b10-bf95-9b6bbf3e96dd","Czech Court Rules Random Identifiers in Health Data Constitute Pseudonymization, Not Anonymization","The Supreme Administrative Court of the Czech Republic clarified a critical distinction under GDPR: adding a random identifier to health datasets does not constitute true anonymization if a third party can use it to re-link records and identify individuals. The court recognized that modern technical capabilities and publicly available information make re-identification feasible, meaning such data retains its 'personal data' status under GDPR. This ruling matters because organizations cannot rely on superficial obfuscation techniques to escape GDPR obligations — genuine anonymization must be irreversible under realistic adversarial conditions. Healthcare and data analytics organizations must rigorously assess re-identification risk before treating any dataset as anonymous and outside the scope of data protection law.","**Immediate actions:**\n- Conduct a formal re-identification risk assessment on all datasets currently classified as 'anonymous' to verify they meet the GDPR standard.\n- Engage a qualified data protection expert or DPO to review any pseudonymization techniques in use against current technical attack capabilities.\n\n**Data governance improvements:**\n- Implement a documented anonymization policy that distinguishes clearly between anonymization and pseudonymization, specifying which GDPR obligations apply to each.\n- Apply privacy-enhancing technologies (e.g., differential privacy, k-anonymity, data aggregation) when sharing health datasets with third parties to reduce re-identification risk.\n- Maintain a data processing register that records the legal basis and anonymization method for every health dataset shared externally.\n\n**Monitoring & compliance measures:**\n- Establish a periodic review process to re-evaluate anonymization techniques as new re-identification methods and public datasets emerge.\n- Ensure data sharing agreements with healthcare consultancies explicitly prohibit re-identification attempts and define enforceable consequences for violations.",[12,13,14,15,16,17,18,19,20,21],"GDPR Article 4(1) — Definition of personal data","GDPR Article 4(5) — Definition of pseudonymisation","GDPR Recital 26 — Principles of anonymization","GDPR Article 9 — Special categories of data (health data)","GDPR Article 25 — Data protection by design and by default","NIST SP 800-188 — De-Identification of Government Datasets","NIST Privacy Framework PR.DP-3 — Data processing minimization","CIS Control 3 — Data Protection","ISO\u002FIEC 29101 — Privacy Architecture Framework","ENISA Pseudonymisation Techniques and Best Practices (2019)","published","2026-08-04T16:21:09.915178+00:00","2026-08-04T16:21:09.805+00:00",{"id":7,"url":26,"slug":27,"title":28},"https:\u002F\u002Fgdprhub.eu\u002Findex.php?title=NSS_-_1_As_183\u002F2023-62&diff=52608&oldid=52595","nss-1-as-183-2023-62-f9a6d0","NSS - 1 As 183\u002F2023-62",[30,36],{"id":31,"name":32,"slug":33,"description":34,"color":35},"c0dcc566-3654-4d70-8ede-262a198e732f","Regulatory Compliance","regulatory-compliance","GDPR, NIS2, DORA, sector-specific violations","#ec4899",{"id":37,"name":38,"slug":39,"description":40,"color":41},"c8b843a5-d5a7-41d1-8d3b-cabded09d2ef","Data Protection","data-protection","Unencrypted data, missing DLP, poor classification","#3b82f6",[]]